Carregant...
Overcoming endocrine resistance in hormone receptor–positive breast cancer
Endocrine therapy, a major modality in the treatment of hormone receptor (hr)–positive breast cancer (bca), has improved outcomes in metastatic and nonmetastatic disease. However, a limiting factor to the use of endocrine therapy in bca is resistance resulting from the development of escape pathways...
Guardat en:
| Publicat a: | Curr Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Multimed Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001756/ https://ncbi.nlm.nih.gov/pubmed/29910644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3752 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|